首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor.
【2h】

Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor.

机译:R型钙通道在大鼠灌注的动脉和静脉肠系膜脉管系统对血小板活化因子的反应中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

1. The vasoactive properties of platelet-activating factor (PAF) were studied in the arterial and venous vasculature of the rat double-perfused mesenteric bed. Although PAF (0.01-0.3 pmol) induced a dose-dependent vasodilatation of the arterial mesenteric vasculature, it triggered only vasoconstrictions on the venous side, with an intact endothelium as bradykinin induced a significant venodilatation. 2. NG-nitro-L-arginine methyl ester (L-NAME, 100 microM), a nitric oxide synthase inhibitor, markedly reduced the vasodilatation induced by PAF in the arterial mesenteric vasculature and potentiated the contractile responses of the venous side to the same agent. 3. The PAF antagonist, WEB-2170, markedly reduced the response to PAF on both sides of the mesenteric vasculature. However, the IC50 of WEB-2170 against PAF was reached at a much higher concentration (1 x 10(-8) M) on the arterial side than on the venous side (5.3 x 10(-11) M). Furthermore, a second antagonist of PAF receptors, SRI-63441, although being less potent on the venous vasculature than WEB-2170, was equipotent in antagonizing the venoconstriction and the arterial dilatation induced by PAF (IC50 of SRI-63441, arterial side: 2.9 x 10(-9) M; venous side: 3.1 x 10(-9) M). 4. The dual L- and R-calcium channel blocker, isradipine (PN 200-110), but not the L-type calcium channel blocker, nifedipine, markedly reduced the PAF-induced vasoactive properties on both sides of the mesenteric vasculature. 5. Our results illustrate the differential vasoactive properties of PAF in the mesenteric vasculature of the rat.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.在大鼠双灌注肠系膜床的动脉和静脉血管系统中研究了血小板活化因子(PAF)的血管活性特性。尽管PAF(0.01-0.3 pmol)诱导了动脉肠系膜血管的剂量依赖性血管舒张,但它仅触发了静脉侧的血管收缩,而完整的内皮细胞则被缓激肽诱导了显着的静脉舒张。 2.一氧化氮合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME,100 microM)显着减少了PAF引起的动脉肠系膜脉管系统的血管舒张作用,并增强了静脉侧对相同血管的收缩反应代理商。 3. PAF拮抗剂WEB-2170明显降低了肠系膜脉管系统两侧对PAF的反应。但是,动脉侧的浓度(1 x 10(-8)M)比静脉侧的浓度(5.3 x 10(-11)M)高得多,达到了WEB-2170对PAF的IC50。此外,PAF受体的第二种拮抗剂SRI-63441虽然在静脉血管系统上的功效不如WEB-2170,但在拮抗PAF引起的静脉收缩和动脉扩张方面是等效的(SRI-63441的IC50,动脉侧:2.9 x 10(-9)M;静脉侧:3.1 x 10(-9)M)。 4.双重L和R钙通道阻滞剂伊拉地平(PN 200-110),而不是L型钙通道阻滞剂硝苯地平,显着降低了PAF诱导的肠系膜脉管两侧的血管活性。 5.我们的结果说明了大鼠肠系膜脉管系统中PAF的不同血管活性。(摘要截短为250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号